← Leaderboards
Martin McCarter
University Of Colorado Denver
$471,992
Attributed
$771,864
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $218.1K · FY2015–21$250K$187.5K$125K$62.5K$0
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$771,864 · 2
By mechanism
R21$771,864 · 2
Top collaborators
- Laurent Gapin2 shared
- Catherine Lozupone2 shared
- Theresa M Medina2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Yuwen Zhu$3,496,594
- V Michael Holers$38,234,826
- David A. Norris$7,265,873
- Kenneth S Krauter$5,478,841
- Mayumi Fujita$5,471,263
Others in their field
Top investigators on “Cancer Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$366,127,178
- Norman Wolmark · Nsabp Foundation, Inc.$292,963,206
- Gregory H Reaman · National Childhood Cancer Foundation$271,061,526
- Peter C Adamson · National Childhood Cancer Foundation$269,808,480
- Charles A Coltman · Southwest Oncology Group$178,303,465
- Sudhir Raju · Ctis, Inc.$162,436,462
Research focus
Cancer TherapyMelanomaImmunotherapyTumorImmune ResponseImmuneResponseMalignant NeoplasmsT-LymphocyteCellsFrequenciesBiological MarkersBindingBaseAntigensBacteriaAutoimmunityAnimal ModelAdvanced DiseaseCell LineageCancer VaccinesAnti-Tumor Immune ResponseCancer TypeAnti-Pd1 Therapy
Grant awards (4)
Improving immunotherapies to melanoma through modulation of MAIT cell activation by the microbiome$218,089
R21 · FY2021 · CA · contact PI
Improving immunotherapies to melanoma through modulation of MAIT cell activation by the microbiome$181,741
R21 · FY2020 · CA · contact PI
Combined ATRA and ipilimumab treatment to reduce immunosuppression in melanoma patients$169,106
R21 · FY2016 · CA · contact PI
Combined ATRA and ipilimumab treatment to reduce immunosuppression in melanoma patients$202,928
R21 · FY2015 · CA · contact PI